Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%

Oxygen Biotherapeutics, Inc. (OXBT)

-NasdaqCM
4.82 Up 0.13(2.77%) 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingApr 30, 2013Apr 30, 2012Apr 30, 2011
Total Revenue 1,234   415   322  
Cost of Revenue43  51  219  
Gross Profit 1,191   364   103  
Operating Expenses
Research Development2,456  2,463  2,682  
Selling General and Administrative3,676  6,092  7,682  
Non Recurring248  30  302  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (5,189) (8,220) (10,563)
Income from Continuing Operations
Total Other Income/Expenses Net12  (80)286  
Earnings Before Interest And Taxes(5,177)(8,300)(10,277)
Interest Expense4,238  7,412  172  
Income Before Tax(9,416)(15,712)(10,448)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(9,416)(15,712)(10,448)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (9,416) (15,712) (10,448)
Preferred Stock And Other Adjustments(958) -   -  
Net Income Applicable To Common Shares (10,374) (15,712) (10,448)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.